Confounding in longitudinal studies in addiction treatment research-Reference-Cited by-同舟云学术

Confounding in longitudinal studies in addiction treatment research

Published:2016-12-22 Issue:3 Volume:25 Page:236-242
ISSN:1606-6359
Container-title:Addiction Research & Theory
language:en
Short-container-title:Addiction Research & Theory

Author:

Pierce Matthias¹,Dunn Graham¹,Millar Tim²

Affiliation:

1. Centre for Biostatistics, Division of Population Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK;

2. National Drug Evidence Centre, Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Publisher

Informa UK Limited

Subject

Medicine (miscellaneous)

Link

https://tandfonline.com/doi/pdf/10.1080/16066359.2016.1247812

Reference36 articles.

1. The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.

2. Bird S. 2008. 21st century drugs and statistical science in UK. Surveys, design and statistics subcommittee of the home. Office Scientific Advisory Committee.

3. Impact of opioid substitution therapy for Scotland's prisoners on drug‐related deaths soon after prisoner release

4. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study

5. Impact of Substance Abuse Treatment on Arrests among Opiate Users in Washington State

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential;Frontiers in Medicine;2024-03-21

2. Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness;Clinical Microbiology and Infection;2021-07

3. Effect of initiating drug treatment on the risk of drug-related poisoning death and acquisitive crime among offending heroin users;International Journal of Drug Policy;2018-01